BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11937438)

  • 1. [What is new in antithrombotic treatment?].
    Mikdame M; Kharchafi A; Toloune F; Archane MI
    Ann Biol Clin (Paris); 2002; 60(2):131-41. PubMed ID: 11937438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging anticoagulants: mechanism of action and future potential.
    Klement P; Rak J
    Vnitr Lek; 2006 Mar; 52 Suppl 1():119-22. PubMed ID: 16637459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New anticoagulants for venous thromboembolic disease.
    Chang P
    IDrugs; 2004 Jan; 7(1):50-7. PubMed ID: 14730467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I; Bajpai A; Camm AJ
    Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different antithrombotic properties of factor Xa inhibitor and thrombin inhibitor in rat thrombosis models.
    Furugohri T; Shiozaki Y; Muramatsu S; Honda Y; Matsumoto C; Isobe K; Sugiyama N
    Eur J Pharmacol; 2005 May; 514(1):35-42. PubMed ID: 15878322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New antithrombotic agents.
    Castelli R; Porro F; Savo D; Cassinerio E
    Panminerva Med; 2006 Dec; 48(4):247-56. PubMed ID: 17215797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [What's new on antithrombotics?].
    Helft G; Leger P
    Ann Cardiol Angeiol (Paris); 2009 Aug; 58(4):230-5. PubMed ID: 18950743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New antithrombotics in the prevention of thromboembolic disease.
    Yavin YY; Wolozinsky M; Cohen AT
    Eur J Intern Med; 2005 Aug; 16(4):257-66. PubMed ID: 16084352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic drugs in vascular medicine: a historical perspective.
    Schrör K
    Semin Vasc Med; 2003 May; 3(2):97-105. PubMed ID: 15199472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current trends in antithrombotic drug and device development.
    Fareed J
    Semin Thromb Hemost; 1996; 22 Suppl 1():3-8. PubMed ID: 8807721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synthetic pentasaccharide fondaparinux: first in the class of antithrombotic agents that selectively inhibit coagulation factor Xa.
    Petitou M; Duchaussoy P; Herbert JM; Duc G; El Hajji M; Branellec JF; Donat F; Necciari J; Cariou R; Bouthier J; Garrigou E
    Semin Thromb Hemost; 2002 Aug; 28(4):393-402. PubMed ID: 12244487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of coagulation factors: advances in antithrombotic therapy.
    Bauer KA
    Semin Thromb Hemost; 2002 Jun; 28 Suppl 2():15-24. PubMed ID: 12073176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melagatran and ximelagatran: new drug. No real simplification of anticoagulant therapy.
    Prescrire Int; 2005 Aug; 14(78):127-32. PubMed ID: 16106594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits.
    Wong PC; Crain EJ; Watson CA; Zaspel AM; Wright MR; Lam PY; Pinto DJ; Wexler RR; Knabb RM
    J Pharmacol Exp Ther; 2002 Dec; 303(3):993-1000. PubMed ID: 12438519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring the new antithrombotic drugs.
    Walenga JM; Hoppensteadt DA
    Semin Thromb Hemost; 2004 Dec; 30(6):683-95. PubMed ID: 15630675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Where to look for progress in antithrombotic treatments?].
    Samama MM
    Rev Prat; 1999 Oct; 49(15):1664-8. PubMed ID: 10581998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in anticoagulation therapy: the role of selective inhibitors of factor Xa and thrombin in thromboprophylaxis after major orthopedic surgery.
    Andersen JC
    Semin Thromb Hemost; 2004 Dec; 30(6):609-18. PubMed ID: 15630666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The direct thrombin inhibitors: their role and use for rational anticoagulation.
    Frenkel EP; Shen YM; Haley BB
    Hematol Oncol Clin North Am; 2005 Feb; 19(1):119-45, vi-vii. PubMed ID: 15639111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of venous thromboembolism: past, present, and future.
    Hyers TM
    Arch Intern Med; 2003 Apr; 163(7):759-68. PubMed ID: 12695266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.